InvestorsHub Logo
Followers 15
Posts 240
Boards Moderated 0
Alias Born 01/31/2018

Re: None

Thursday, 04/30/2020 1:41:13 AM

Thursday, April 30, 2020 1:41:13 AM

Post# of 232952
Fauci is clear- he wants a cocktail. First, Remdesivir to reduce virus replication. The second is, very specifically, a MAB with antiinflamatory properties.

Besides leronlimab, there is only one other fitting the description: Tocilizumab/Actemra by Roche. It seems the wise route would be trials of each in combination with Remdesivir.

That's all we should ask.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News